viernes, 23 febrero, 2018
Journal Gastroentelogy, Febrero 2018

Esophageal cancer stem cells are suppressed by tranilast, a TRPV2 channel inhibitor

Journal of Gastroenterology First published: 07 April 2017 DOI: https://doi.org/10.1007/s00535-017-1426-y Atsushi Shiozaki, Michihiro Kudou, Daisuke Ichikawa, Hitoshi Fujiwara, Hiroki Shimizu, Takeshi Ishimoto, Tomohiro Arita, Toshiyuki Kosuga, Hirotaka Konishi, Shuhei Komatsu, Kazuma Okamoto, Yoshinori Marunaka, Eigo Otsuji Objective: Recent evidence suggests that the targeting of membrane proteins specifically activated in cancer stem cells (CSCs) is an important...
Journal Gastroentelogy, Febrero 2018

Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application...

Journal of Gastroenterology First published: 30 November 2017 DOI: https://doi.org/10.1007/s00535-017-1416-0  Yoichi Kakuta, Yoshitaka Kinouchi, Tooru Shimosegawa Objective: Inflammatory bowel diseases (IBDs), represented by ulcerative colitis and Crohn’s disease, are chronic inflammatory intestinal conditions of unknown...
Alimentary Pharmacology and Therapeutics

Infliximab trough concentrations during maintenance therapy are associated with endoscopic and histologic healing in...

Alimentary Pharmacology & Therapeutics First published: 6 December 2017 DOI: 10.1111/apt.14458 K. Papamichael, S. Rakowsky, C. Rivera, A. S. Cheifetz, M. T. Osterman Objective: Endoscopic and histologic healing are...
Alimentary Pharmacology and Therapeutics

Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a...

Alimentary Pharmacology & Therapeutics First published: 18 December 2017 DOI: 10.1111/apt.14419 S. Tadbiri, L. Peyrin-Biroulet, M. Serrero, J. Filippi, B. Pariente, X. Roblin, A. Buisson, C. Stefanescu, C. Trang-Poisson, R. Altwegg, P. Marteau, T. Vaysse, A. Bourrier, S. Nancey, D. Laharie, M. Allez, G....

Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial

The Lancet Gastroenterology & Hepatology First published: 31 January 2018 DOI: https://doi.org/10.1016/S2468-1253(18)30009-8 Derek J Jonker, MD, Derek J JonkerEmail the author MD Derek J Jonker, Louise Nott, MBBS, Takayuki...
The Lancet - Marzo 2018

Perioperative lipid-enriched enteral nutrition versus standard care in patients undergoing elective colorectal surgery (SANICS...

The Lancet Gastroenterology & Hepatology First published: 06 February 2018 DOI: https://doi.org/10.1016/S2468-1253(18)30031-1 Emmeline G Peters , MD †, Boudewijn JJ Smeets , MD †, Jesper Nors , BSc, Christian...

Time to end treatment restrictions for people with hepatitis C who inject drugs

The Lancet Gastroenterology & Hepatology First published: 05 January 2018 DOI: http://dx.doi.org/10.1016/S2468-1253(18)30001-3 Elana S Rosenthal, Sarah Kattakuzhy, Shyam Kottilil Objective: Hepatitis C virus (HCV) is a major cause...

Clinical features of chronic enteropathy associated with SLCO2A1 gene: a new entity clinically distinct...

Journal of Gastroenterology First published: 08 January 2018 DOI: https://doi.org/10.1007/s00535-017-1426-y Umeno, J., Esaki, M., Hirano, A. Objective: Chronic enteropathy associated with SLCO2A1 gene (CEAS) is a hereditary disease caused by mutations...